Education
About Us
Working with TipRanks
Follow Us
China Shineway Pharmaceutical Group Limited (HK:2877)
:2877
RESEARCH TOOLSreports
2877 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$6.96 - HK$10.76
Previous CloseN/A
Volume914.00K
Average Volume (3M)1.09M
Market Cap
HK$6.27B
Enterprise ValueHK$43.85M
Total Cash (Recent Filing)HK$6.49B
Total Debt (Recent Filing)¥346.53M
Price to Earnings (P/E)6.9
Beta0.59
Next Earnings
Sep 02, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 30, 2025Dividend Yield0.85%
Share Statistics
EPS (TTM)0.31
Shares Outstanding827,000,000
10 Day Avg. Volume1,186,910
30 Day Avg. Volume1,090,764
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.79
Price to Sales (P/S)0.00
P/FCF Ratio5.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$8.50Price Target Upside3.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
China Shineway Pharmaceutical Group Limited News
PremiumCompany Announcements
China Shineway Appoints New Nomination Committee Member
PremiumCompany Announcements
China Shineway Pharmaceutical Updates Nomination Committee TermsPremiumCompany Announcements
China Shineway Pharmaceutical Announces New Board of Directors
PremiumCompany Announcements
China Shineway Pharmaceutical Successfully Passes All AGM Resolutions
PremiumCompany Announcements
China Shineway Reports 31.9% Decline in Q1 2025 Turnover
PremiumCompany Announcements
China Shineway Pharmaceutical Announces 2025 AGM Agenda
PremiumCompany Announcements
China Shineway Announces Interim Dividend for FY2025Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.59%
Mutual Funds
― Other Institutional Investors
96.58% Public Companies and
Individual Investors
2877 FAQ
What was China Shineway Pharmaceutical Group Limited’s price range in the past 12 months?
China Shineway Pharmaceutical Group Limited lowest stock price was HK$6.96 and its highest was HK$10.76 in the past 12 months.
What is China Shineway Pharmaceutical Group Limited’s market cap?
China Shineway Pharmaceutical Group Limited’s market cap is HK$6.27B.
When is China Shineway Pharmaceutical Group Limited’s upcoming earnings report date?
China Shineway Pharmaceutical Group Limited’s upcoming earnings report date is Sep 02, 2025 which is in 40 days.
How were China Shineway Pharmaceutical Group Limited’s earnings last quarter?
China Shineway Pharmaceutical Group Limited released its earnings results on Mar 28, 2025. The company reported HK$0.307 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.307.
Is China Shineway Pharmaceutical Group Limited overvalued?
According to Wall Street analysts China Shineway Pharmaceutical Group Limited’s price is currently Undervalued.
Does China Shineway Pharmaceutical Group Limited pay dividends?
China Shineway Pharmaceutical Group Limited pays a Semiannually dividend of HK$0.385 which represents an annual dividend yield of 0.85%. See more information on China Shineway Pharmaceutical Group Limited dividends here
What is China Shineway Pharmaceutical Group Limited’s EPS estimate?
China Shineway Pharmaceutical Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Shineway Pharmaceutical Group Limited have?
China Shineway Pharmaceutical Group Limited has 827,000,000 shares outstanding.
What happened to China Shineway Pharmaceutical Group Limited’s price movement after its last earnings report?
China Shineway Pharmaceutical Group Limited reported an EPS of HK$0.307 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -8.273%.
Which hedge fund is a major shareholder of China Shineway Pharmaceutical Group Limited?
Currently, no hedge funds are holding shares in HK:2877
China Shineway Pharmaceutical Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
10.44%
12-Months-Change
Fundamentals
Return on Equity
11.61%
Trailing 12-Months
Asset Growth
1.38%
Trailing 12-Months
Company Description
China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited (2877) is a leading pharmaceutical company in China, specializing in the research, development, manufacturing, and distribution of traditional Chinese medicine (TCM) and modern pharmaceuticals. The company operates in the healthcare sector, offering a diverse range of products including injections, soft capsules, granules, and other herbal-based medical solutions. Shineway is recognized for its commitment to quality and innovation in providing effective healthcare products to meet the needs of patients both domestically and internationally.
Technical Analysis
Shandong Xinhua Pharmaceutical Company Limited Class H
―
Jacobson Pharma Corporation Limited
―
Pak Fah Yeow International Limited
―
Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. Class H
―
China Traditional Chinese Medicine Holdings Co
―